Vanda Pharmaceuticals
@vandapharma
Followers
2K
Following
37
Media
59
Statuses
174
Vanda is a global pharmaceutical company focused on the development of innovative therapies to address unmet medical needs and improve the lives of patients.
Washington DC
Joined November 2009
In a Major Win for Vanda, a Federal Appeals Court Overturns FDA's Order Denying Approval of Hetlioz for the Treatm.
prnewswire.com
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that it secured a landmark victory over the U.S. Food and Drug Administration...
27
18
100
Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results
1
0
4
Happy 4th of July!.
Nationals’ Jacob Young looks like Spider-Man with unreal wall-scaling catch
1
2
8
Vanda is proud to sponsor the #MallorcaChampionships .
0
0
3
The Effect of Iloperidone on Hostility in Schizophrenia Patients: Post Hoc Analysis from a Randomized, Placebo-controlled Trial.
4
11
57
Vanda is proud to have supported an amazing @NHL season @NHL_On_TNT. Congratulations to @FlaPanthers on winning the @StanleyCup!.
1
0
0
Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease .
5
7
35
Today, we remember the thousands of U.S. Soldiers and Allied troops who landed on Normandy’s shores 81 years ago. We also remember the thousands of U.S. Soldiers who paid the ultimate sacrifice. We encourage all Americans to take a moment to honor those who risked their lives
0
0
5
We @vandapharma would like to thank everyone who visited with us at the Consortium of Multiple Sclerosis Centers Annual Meeting in Phoenix, AZ @mscare
0
1
10
Phase 3 OPTIMUM Extension study further highlights Sustained Efficacy and Safety of Ponesimod via @neurology_live.
neurologylive.com
New long-term data reveals ponesimod's effectiveness in reducing relapses and MRI lesions in relapsing multiple sclerosis patients, ensuring safety over 8.2 years.
0
3
28
1
2
7
Antipsychotic drug Bysanti™ data presented at ASCP 2025 Annual Meeting in Scottsdale, AZ
1
5
16
@vandapharma is at the #CMSC Consortium of MS Centers 2025 Annual Meeting in Phoenix, AZ from May 28-31. Come visit us!
0
1
2
@Vandapharma would like to thank everyone who visited with us at the American Psychological Association Annual Meeting in Los Angeles.
2
1
3
RT @MonSportsNet: Check out the updated digs 🙌. The @WashMystics have partnered with @vandapharma for the 2025 season, further investing in….
0
8
0
RT @MSE: 📰 MSE has announced @vandapharma as an official partner and the jersey patch partner for the @WashMystics. Vanda's logo will be di….
0
9
0
A study published today in The British Journal of Psychiatry shows that VQW-765, an alpha 7-nicotinic acetylcholine receptor agonist, shows promise in the treatment of social anxiety disorder -
7
9
58
Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results
prnewswire.com
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the first quarter ended March 31, 2025....
1
1
22
Vanda Announces Bysanti™ NDA Filing; FDA Decision Expected in Early 2026
prnewswire.com
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New...
2
4
14